HomepageBlogEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine Blog IndustryEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine admin Posted on August 14, 2023 Evonik Industries AG supplies lipids essential to production of the Pfizer–BioNTech COVID-19 vaccine, in which messenger RNA (mRNA) is enclosed……Please subscribe to read the full story.Author admin View all posts Post navigationPrevious PostMitsubishi Chemical to Mass-Produce GaN Substrates for More Energy-Efficient Vehicles, Devices Next PostJSR to Boost Production Capacity for Advanced Semiconductor PhotoresistsYou Might Also Like BlogToray Pursues Environmental Friendliness Through Artificial Leather admin August 14, 2023 BlogTerabo Develops Resin Compound Technology Using Eggshell as Filler admin August 14, 2023 BlogUbe to Decide on Increasing PA Elastomer Production During First Half admin August 14, 2023 BlogUnderstanding the Basics of Acid-Base Chemistry admin January 2, 2024